Impact of the COVID-19 Pandemic on Ovarian Cancer Management: Adapting to the New Normal

Impact of the COVID-19 Pandemic on Ovarian Cancer Management: Adapting to the New Normal

The Gynecologic Oncology Institute focuses on ovarian cancer and supports all efforts to get care back to normal as soon as possible.  This is another form of collateral damage due to the pandemic and it certainly hits our patients close to home.

Out treatment plans include outpatient care as much as possible, including outpatient robotic surgery, which is minimally invasive and gets you out of the hospital the same day or the next morning.  This applies even to advanced cancer cases but requires a personal evaluation to see if that is in your best interests overall.

Cancer Manag Res. 2021, Jan. 14; 13: 359-366. doi: 10.2147 / CMAR.S287152. eCollection 2021.


COVID-19, also known as Coronavirus Disease 2019, is caused by the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), which has been declared a pandemic by the World Health Organization (WHO). As the world faces the 2019 coronavirus disease crisis, oncology is facing unprecedented challenges. During this difficult time, ovarian cancer (OC) patients experienced delays in diagnosis, surgery, chemotherapy, and radiation, and oncology follow-ups were conducted via telemedicine rather than face-to-face visits. OC patients and their oncologists are balancing fears of COVID-19 and cancer treatment with the consequences of delaying cancer treatment. The delay in treating women with OC has led to higher levels of cancer concerns, anxiety, and depression. This article briefly examines the diagnosis and treatment impact of the COVID-19 pandemic, as well as the ongoing clinical trials on OC. We also discuss the psychological effects of COVID-19 on women with OC and alternative therapeutic strategies to limit personal hospital visits to reduce the spread of the disease, as well as the effects of COVID-19 on OC patients.

PMID: 33469377 | PMC: PMC7813454 | DOI: 10.2147 / CMAR.S287152

Source link

Previous articleCan endometrial cancer be treated with immunotherapy?
Next articlePembrolizumab Plus lenvatinib significantly improves survival in advanced endometrial cancer
“I help and guide women to defeat gynecologic cancers and advanced pelvic conditions such as endometriosis, using a unique combination of minimally invasive robotic surgery, precision medicine therapies and complementary holistic natural support towards thriving in survivorship." Dr. Vasilev is the only physician quadruple board certified in Ob-Gyn, Gynecologic Oncology and Integrative & Holistic Medicine in the United States. He is an accomplished advanced robotic surgeon and serves as Medical Director of Integrative Medicine and Integrative Gynecologic Oncology at Providence Saint John's Health Center, Professor at John Wayne Cancer Institute in Santa Monica, California and is Clinical Professor at Loma Linda University School of Medicine. He is former faculty and professor at UC Irvine, UCLA, USC and City of Hope. He is an active member of multiple medical societies and has been nationally listed in "Best Doctors" for 18 years.